| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 83.54B | 100.96B | 87.27B | 89.10B | 73.52B | 81.54B |
| Gross Profit | 72.30B | 87.20B | 76.34B | 79.16B | 62.62B | 72.45B |
| EBITDA | 15.66B | 26.70B | 20.94B | 22.05B | 9.66B | 21.01B |
| Net Income | 8.12B | 16.57B | 11.05B | 10.19B | 1.95B | 13.15B |
Balance Sheet | ||||||
| Total Assets | 1.22T | 1.53T | 1.41T | 1.40T | 1.06T | 1.58T |
| Cash, Cash Equivalents and Short-Term Investments | 404.50B | 490.04B | 531.91B | 417.00B | 392.46B | 618.89B |
| Total Debt | 650.49B | 394.60B | 388.26B | 643.97B | 521.81B | 752.38B |
| Total Liabilities | 1.03T | 1.32T | 1.21T | 1.21T | 874.67B | 1.40T |
| Stockholders Equity | 178.94B | 194.90B | 181.92B | 180.27B | 169.83B | 173.23B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 29.40B | 20.39B | 10.61B | 104.19B | 1.49B |
| Operating Cash Flow | 0.00 | 30.88B | 20.78B | 12.81B | 107.31B | 5.67B |
| Investing Cash Flow | -24.36B | -47.40B | -24.36B | -42.57B | -18.62B | -23.01B |
| Financing Cash Flow | 17.66B | -2.21B | 17.66B | -4.53B | -57.59B | 32.35B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥59.99B | 10.05 | 17.21% | 4.27% | 11.13% | 20.95% | |
72 Outperform | ¥2.09T | 3.01 | 20.02% | 2.63% | 31.37% | 148.24% | |
70 Outperform | ¥40.80B | 10.52 | 6.18% | 4.42% | 30.88% | 193.36% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
67 Neutral | ¥170.87B | 10.82 | 7.40% | 5.60% | 15.68% | 49.07% | |
67 Neutral | ¥113.30B | 18.28 | 5.11% | 5.07% | -26.93% | -29.39% | |
53 Neutral | ¥25.09B | -8.03 | ― | ― | -45.54% | -286.03% |